Spinal anesthetic management for discectomy in a patient with amyotrophic lateral sclerosis -A case report-

Park, Ki-Bum; Byungdoo Son; Hwang, Doo-Youn; Younghoon Jeon
December 2012
Korean Journal of Anesthesiology;Dec2012, Vol. 63 Issue 6, p547
Academic Journal
Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig's disease, is a degenerative disorder of motor neuron system of the spinal cord and the cortical neuron. Patients with ALS present a unique challenge to the anesthesiologist. Respiratory muscle weakness, for instance, can result in trouble with proper breathing after general anesthesia. We report a case of spinal anesthesia for discectomy in a patient with ALS.


Related Articles

  • 28: Lithium Treatment for ALS. Bosveld, Jane // Discover;Jan2009, Vol. 30 Issue 1, p40 

    The article discusses research which suggests that treatment for amyotrophic lateral sclerosis (ALS) may be improved by incorporating a drug which contains riluzole and lithium. Lithium has been found to counteract the damage of motor neurons and stimulate the production of mitochondria. The...

  • Physical Therapy for a Patient Through Six Stages of Amyotrophic Lateral Sclerosis. Bello-Haas, Vanina Dal; Kloos, Anne D. // Physical Therapy;Dec1998, Vol. 78 Issue 12, p1312 

    Describes the use of Sinaki and Mulder's approach to staging amyotrophic lateral sclerosis (ALS). Functional outcome measures in designing a treatment program for a 59-year-old woman with ALS; Case description and outcomes; Discussion; Details on how physical therapists can assist patients with...

  • Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. Fumitaka Shimizu; Masatoshi Omoto; Yasuteru Sano; Naoko Mastui; Ai Miyashiro; Ayako Tasaki; Toshihiko Maeda; Michiaki Koga; Ryuji Kaji; Takashi Kanda // Journal of Neurology, Neurosurgery & Psychiatry;May2014, Vol. 85 Issue 5, p526 

    Objective In multifocal motor neuropathy (MMN), the destruction of the blood-nerve barrier (BNB) has been considered to be the key step in the disease process. The purpose of the present study was to ascertain whether sera from patients with MMN can open the BNB, and which component of patient...

  • Case report: Maintaining and withdrawing long-term invasive ventilation in a patient with MND/ALS in a home setting. LeBon, B.; Fisher, S. // Palliative Medicine;4/1/2011, Vol. 25 Issue 3, p262 

    Long-term home-based invasive ventilation in patients with motor neurone disease / amyotrophic lateral sclerosis (MND/ ALS) remains rare in the UK. We describe a case of an MND/ALS patient who was treated with long-term invasive ventilation at home but subsequently requested its withdrawal...

  • Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment. Devigili, Grazia; ��eyler, Nurcan; Beck, Marcus; Reiners, Karlheinz; Stoll, Guido; Toyka, Klaus; Sommer, Claudia // Acta Neuropathologica;Sep2011, Vol. 122 Issue 3, p343 

    Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with variable involvement of other systems. A pathogenetic role of immune-mediated mechanisms has been suggested. We retrospectively analyzed sural nerve pathology and the clinical course in 18 patients with ALS. These patients...

  • Neurodegenerative disease: Giving survival a boost. Whalley, Katherine // Nature Reviews Neuroscience;Dec2008, Vol. 9 Issue 12, p887 

    The article reflects on a study focusing on the replacement of damaged astrocytes through precursor cell transplantation that may be a useful therapeutic strategy for amyotrophic lateral sclerosis (ALS). The author suggests that the transplantation of precursors to substitute damaged astrocytes...

  • AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS. Hester, Mark E.; Foust, Kevin D.; Kaspar, Rita W.; Kaspar, Brian K. // Current Gene Therapy;Oct2009, Vol. 9 Issue 5, p428 

    Therapeutic delivery to the central nervous system has challenged scientists and clinicians due to the difficulty in delivering molecules and genes in an efficient manner across the blood brain barrier (BBB). This has particularly hampered efforts to deliver therapeutics to widely dispersed...

  • Treatment of amyotrophic lateral sclerosis — What is the next step? Ludolph, A.C. // Journal of Neurology;Dec2000 Supplement 6, Vol. 247, pVI13 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease which was thought to be untreatable. However, recent evidence in both experimental animals and men indicates that antiglutamatergic strategies are the first to have an influence on its pathogenesis and slow down the disease...

  • Screen Reveals Compounds Against ALS. Tolchin, Elizabeth // Drug Discovery & Development;May2005, Vol. 8 Issue 5, p22 

    Reports on researchers' identification of a set of virtual compounds they believe could lead to promising therapies for inherited forms of the muscle-rippling disease amyotrophic lateral sclerosis (ALS). Compounds' prevention of the mutant protein SOD1 from clumping; Use of a computer platform...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics